Health Matters: Speeding up drug discovery & new COVID-19 variant now dominant in Alberta

Health Matters March 23: The University of Alberta is leading a national research network that’s studying glycomics – and how the science can accelerate drug discovery. Also, Alberta Health confirms the Omicron subvariant BA.2 is now the dominant COVID-19 strain in the province. Su-Ling Goh reports.